A Doctor's Take: Cyclospora or Salmonella? The Key Differences and How to Protect Yourself

Recent outbreaks of foodborne illness, like the cyclosporiasis cases that have led to hundreds of illnesses, two deaths and produce recalls in several states, remind us that food safety is an ongoing concern. 

Pathogens like Cyclospora and Salmonella each bring their own risks. Knowing how they differ can help you ma...

Hormone Therapy Might Lower Dementia Risk Among Women

Hormone therapy might reduce the risk of dementia in women after menopause, a new study says.

Women who received hormone therapy had a 16% lower risk of developing Alzheimer’s disease, researchers reported Aug. 26 in the journal Alzheimer’s & Dementia.

The benefits were greatest for women who’d undergon...

Sticking To BP Meds Lowers Heart Risk, Study Finds

Folks who think missing a dose of blood pressure medication here or there won’t harm their health should probably think again, a new study says.

Regularly missing doses not only blunts the effectiveness of blood pressure drugs, but also increases risk of stroke or heart attack, researchers will report this weekend at the European Soc...

A Third Of Women In Their 20s Haven't Gotten This Essential Cancer Screening

Nearly a third of women in their 20s have never been screened for cervical cancer, increasing their risk of disease and death, a new study says.

Women are urged to start cervical cancer screening at either 21 or 25, based on competing guidelines by the American College of Obstetrics & Gynecology and the American Cancer Society.

B...

FDA Approves First Pill To Extend Survival In Advanced Pancreatic Cancer

The U.S. Food and Drug Administration (FDA) has approved the first drug shown to substantially extend the lives of people with advanced pancreatic cancer, nearly doubling survival time in a key clinical trial.

The pill, Rasonque (daraxonrasib), was cleared Wednesday for adults whose pancreatic cancer has spread and who have already had at ...

Thyroid Tablets Recalled Nationwide Due To Potential Over-Potency Risk

More than 3,600 bottles of a common thyroid medication are being recalled nationwide because lab testing showed the pills could be too strong.

Vitruvias Therapeutics, based in Auburn, Alabama, initiated the voluntary recall for a single batch of Thyroid Tablets, USP 30 mg. 

The medication helps to restore normal hormone levels a...